EyePoint

(NASDAQ) EYPT

Current Price$13.65

Market Cap$1.14B

Since IPO (2008)-57%

5 Year+40%

1 Year+124%

1 Month-4%

EyePoint Financials at a Glance

Market Cap

$1.14B

Revenue (TTM)

$7.62M

Net Income (TTM)

$271.60M

EPS (TTM)

$-3.50

P/E Ratio

-3.90

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$13.65

Volume

661,535.713

Open

$13.35

Price

$13.65

Volume

661,535.713

Open

$13.35

Previous Close

$13.66

Daily Range

$13.29 - $13.75

52-Week Range

$5.30 - $19.11

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$13.65

Volume

661,535.713

Open

$13.35

Previous Close

$13.66

Daily Range

$13.29 - $13.75

52-Week Range

$5.30 - $19.11

EYPT News

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

Jonathan PoncianoMar 15, 2026

Page 1

EYPT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About EyePoint

Industry

Pharmaceuticals

Sector

Health Care

Employees

214

CEO

Jay S. Duker, MD

Website

www.eyepointpharma.com

Headquarters

Watertown, MA 02472, US

EYPT Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

-37%

Net Income Margin

-36%

Return on Equity

-103%

Return on Capital

-1%

Return on Assets

-94%

Earnings Yield

-25.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.14B

Shares Outstanding

83.80M

Volume

661.54K

Avg. Volume

1.27M

Financials (TTM)

Gross Profit

$29.30M

Operating Income

$243.43M

EBITDA

$243.43M

Operating Cash Flow

$240.11M

Capital Expenditure

$3.28M

Free Cash Flow

$243.39M

Cash & ST Invst.

$306.09M

Total Debt

$20.77M

EyePoint Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$696.00K

-97.2%

Gross Profit

$168.00K

-99.3%

Gross Margin

24.14%

N/A

Market Cap

$1.14B

N/A

Market Cap/Employee

$6.94M

N/A

Employees

165

N/A

Net Income

$84.83M

-87.7%

EBITDA

$87.23M

-80.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$202.31M

-31.2%

Accounts Receivable

$1.16M

+161.8%

Inventory

$1.25M

-41.3%

Long Term Debt

$20.23M

-9.3%

Short Term Debt

$0.00

-100.0%

Return on Assets

-94.23%

N/A

Return on Invested Capital

-1.12%

N/A

Free Cash Flow

$81.55M

-52.7%

Operating Cash Flow

$80.55M

-51.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SEPNSepterna, Inc.

SEPNSepterna, Inc.$23.87-0.46%

SVRASavara Inc.

SVRASavara Inc.$5.23+1.36%

BCAXBicara Therapeutics Inc. Common Stock

BCAXBicara Therapeutics Inc. Common Stock$22.58-2.21%

NRIXNurix Therapeutics, Inc.

NRIXNurix Therapeutics, Inc.$16.52+1.47%

KURAKura Oncology, Inc.

KURAKura Oncology, Inc.$9.42+1.07%

PRMEPrime Medicine, Inc.

PRMEPrime Medicine, Inc.$3.21+3.05%

PROKProKidney Corp.

PROKProKidney Corp.$1.86-1.06%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

NOKNokia

NOKNokia$12.82+0.04%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.35+0.01%

Questions About EYPT

What is the current price of EyePoint?

EyePoint is trading at $13.66 per share.

What is the 52-week range for EyePoint?

Over the past 52 weeks, EyePoint has traded between $5.30 and $19.11.

How much debt does EyePoint have?

As of the most recent reporting period, EyePoint reported total debt of $22.31M.

How much cash does EyePoint have on hand?

EyePoint reported $77.71M in cash and cash equivalents in its most recent financial results.

What is EyePoint’s dividend yield?

EyePoint does not currently have a dividend yield.

EyePoint

EyePoint Financials at a Glance

EYPT News

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

EyePoint (EYPT) Q2 Revenue Drops 44%

Why Shares of EyePoint Pharmaceuticals Were Rising Monday

Why EyePoint Pharmaceuticals Shot 31% Higher Today

Why EyePoint Pharmaceuticals Is Cratering Today

3 Top Small-Cap Stocks to Buy in October

3 Top Biotech Stocks to Buy in September

Keep Your Eye on These 4 Healthcare Stocks

EYPT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About EyePoint

EYPT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

EyePoint Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EYPT

What is the current price of EyePoint?

What is the 52-week range for EyePoint?

How much debt does EyePoint have?

How much cash does EyePoint have on hand?

What is EyePoint’s dividend yield?

Premium Investing Services